BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 37344894)

  • 1. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants.
    Sharifi E; Yousefiasl S; Trovato M; Sartorius R; Esmaeili Y; Goodarzi H; Ghomi M; Bigham A; Moghaddam FD; Heidarifard M; Pourmotabed S; Nazarzadeh Zare E; Paiva-Santos AC; Rabiee N; Wang X; Tay FR
    J Nanobiotechnology; 2023 Jun; 21(1):199. PubMed ID: 37344894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Antiviral and Anti-Inflammatory Activities of
    Marchetti M; De Berardis B; Bigioni I; Mariano A; Superti F; Scotto d'Abusco A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    Belser JA; Sun X; Kieran TJ; Brock N; Pulit-Penaloza JA; Pappas C; Basu Thakur P; Jones J; Wentworth DE; Zhou B; Tumpey TM; Maines TR
    J Virol; 2022 Dec; 96(24):e0140322. PubMed ID: 36448801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.
    Boehm AB; Hughes B; Duong D; Chan-Herur V; Buchman A; Wolfe MK; White BJ
    Lancet Microbe; 2023 May; 4(5):e340-e348. PubMed ID: 36965504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of yogurt containing probiotics on respiratory virus infections: Influenza H1N1 and SARS-CoV-2.
    Jeon HY; Kim KS; Kim S
    J Dairy Sci; 2023 Mar; 106(3):1549-1561. PubMed ID: 36631322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnologies for the Diagnosis and Treatment of SARS-CoV-2 and Its Variants.
    Park E; Choi SY; Kim J; Hildebrandt N; Lee JS; Nam JM
    Small Methods; 2023 Jul; 7(7):e2300034. PubMed ID: 37189215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo.
    Zhao H; Zhang C; Lam H; Meng X; Peng Z; Yeung ML; Chan JF; Kai-Wang To K; Yuen KY
    Signal Transduct Target Ther; 2022 Aug; 7(1):266. PubMed ID: 35922403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
    Zhao H; Meng X; Peng Z; Lam H; Zhang C; Zhou X; Chan JF; Kao RYT; To KK; Yuen KY
    Emerg Microbes Infect; 2022 Dec; 11(1):926-937. PubMed ID: 35259078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
    J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD.
    Li Y; Liu P; Hao T; Liu S; Wang X; Xie Y; Xu K; Lei W; Zhang C; Han P; Li Y; Jin X; Huan Y; Lu Y; Zhang R; Li X; Zhao X; Xu K; Liao P; Lu X; Bi Y; Song H; Wu G; Zhu B; Gao GF
    Emerg Microbes Infect; 2023 Dec; 12(2):2231573. PubMed ID: 37394992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.
    Dawre S; Maru S
    Life Sci; 2021 Aug; 278():119561. PubMed ID: 33915132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Border Control for Infectious Respiratory Disease Pandemics: A Modelling Study for H1N1 and Four Strains of SARS-CoV-2.
    Lim NW; Lim JT; Dickens BL
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant.
    Peled Y; Afek A; Kreiss Y; Rahav G; Nemet I; Kliker L; Indenbaum V; Ram E; Lavee J; Segev A; Matezki S; Sternik L; Raanani E; Lustig Y; Patel JK; Mandelboim M
    J Heart Lung Transplant; 2022 Oct; 41(10):1417-1425. PubMed ID: 35710484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses.
    Saksena NK; Reddy SB; Miranda-Saksena M; Cardoso THS; Silva EMA; Ferreira JC; Rabeh WM
    Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166836. PubMed ID: 37549720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.